CLINICAL_TRIALS
trial_result
· 2025-02-27
Clinical Trial Update: Melatonin in Patients With Multiple Sclerosis (MS). [EARLY_Phase 1]
Summary
An early-phase study evaluating melatonin in relapsing-remitting multiple sclerosis has completed, with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Providence Health & Services | Conditions: Relapsing Remitting Multiple Sclerosis | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2025-02-27